Comparison of comparative genomic hybridization, fluorescence in situ hybridization and flow cytometry in urinary bladder cancer

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 7-12

  Mahdy, Ensaf ^a,b   Yoshihiro, Saturu ^b   Zech, Lore ^a   Wester, Kenneth ^a   Pan, Yi ^b   Busch, Christer ^a   Döhner, Hartmut ^d   Kallioniemi, Olli ^c   Bergerheim, Ulf ^b   Malmström, Per Uno ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d Department of Hematology ^*  (Germany)

Author keywords

CGH; Chromosome; FISH; TCC

Indexed keywords

PROTEIN P53;

ANEUPLOIDY; ARTICLE; BLADDER CANCER; CANCER STAGING; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 17P; CHROMOSOME 2; CHROMOSOME 7; CHROMOSOME 8Q; CHROMOSOME 9; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIPLOIDY; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DELETION; GENE INSERTION; GENE SEQUENCE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; METHODOLOGY; MITOSIS INDEX; MOLECULAR GENETICS; MUTATION RATE; PRIORITY JOURNAL;

CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION; URINARY BLADDER NEOPLASMS;

EID: 0032953678     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rubben H, Lutzeyer W, Wallace DMA: The epidemiology and etiology of bladder cancer. Bladder Cancer. Spring-Verlag, Berlin, Heidelberg, 1985.
2. Bahu VR, Lutz MD, Miles BJ, Farah RN, Weiss L, Van Dyke DL: Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res 47: 6800-6805, 1987.
3. Berger CS, Sandberg AA, Todd IA, Pennington RD, Haddad FS, Hecht BK, Hecht F: Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet 23: 1-24, 1986.
4. Gibas Z, Prout GR, Jr. Connolly JG, Pontes JE, Sandberg AA: Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 44: 1257-1264, 1984.
5. Sandberg AA, Berger CS: Review of chromosome studies in urological tumors: II. Cytogenetics and molecular genetics of blad:der cancer. J Urol 151: 545-560, 1994.
6. Vanni R, Peretti D, Scarpa RM, Usai E: Derivative 11 marker chromosome in bladder carcinoma. Cancer Genet Cytogenet 164: 289-295, 1985.
7. Hopman AH, Poddighe PJ, Smeets AW, Moesker O, Beck JL, Vooijs GP, Ramaekers FC: Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 135: 1105-1117, 1989.
8. Hopman AHN, Moesker O, Smeets AWGB, Pauwels RPE, Vooijs GP, Ramaekers FCS: Numerical chromosome 1,7,9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51: 644-651, 1991.
9. Waldman FM, Caroll PR, Kerschmann R, Cohen MB, Field FG, Mayall BH: Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer. Cancer Res 51: 3807-3813, 1991.
10. Kallioniemi A, Kallioniemi O, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
11. Hedley DW, Friedlander M, Taylor IW, Rugg CA, Musgrowe E: Method for analysis of cellular DNA content of paraffin-embeded pathological material using flow cytometry. J Histochem Cytochem 31: 1333-1335, 1983.
12. Vindelove LL, Christensen IJ, Nissen NI: A detergent trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 3: 323-327, 1983.
13. Seigneurin D, Rambeaud JJ, Bosio C, Louis J: DNA image cytometry of bladder tumours: Comparison of washings and tumour imprints from 61 patients. Anal Cell Pathol 5: 39-48, 1993.
14. Cattoretti G, Pileri S, Parravicini C, Becker MH, Pogg S, Bifulco C, Key G, Amato L, Sabattini E, Feudale E: Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 171: 83-98, 1993.
15. Malmstrsom P-U, Vasko J, Wester K, Norlen BJ, Busch C: Flow cytometric analysis of DNA content of deparaffinized nuclei in, urinary bladder carcinomas. Comparison of different isolation methods and relation to histological grade and stage. APMIS 97: 811-819, 1989.
16. Gonzalez-Zulueta M, Shibata A, Ohneseit PF, Spruck CH, Busch C, Shamaa MEM, Nichols PW, Gonzalgo ML, Malmstrom P-U, Jones PA: High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in sequamous cell carcinoma of the bladder. J Nat Can Inst Vol 878: 1383-1393, 1995.
17. Busch C, Vasko J: Differential staining of mitoses in tissue sections and cultured cells by a modified methenamine-silver method. Lab Invest 59: 876-878, 1988.
18. Vasko J, Malmstrom P-U, Wester K, Busch C: Prognostic value of a systematized method for determination of mitotic frequency in bladder cancer assisted by image analysis. J Urogenital Pathol 1: 53-59, 1991.
19. Matsuyama H, Pan Y, Mahdy EA, Malmstrsom P-U, Hedrum A, Uhlen M, Busch C, Hirano T, Auer G, Tribukait B, Naito K, Lichter P, Ekman P, Bergerheim USR: P53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res 54: 6057-6060, 1994.
20. Lichter P, Cremer T, Borden J, Manuelidis L, Ward DC: Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum Genet 80: 224-234, 1988.
21. Maniatis T, Fritsch EF, Sambrook J: Molecular Cloning, A Laboratory Manual. Cold Spring Harbor, NY. Cold Spring Harbor Laboratory Press, 1982.
22. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243, 1994.
23. Piper J, Rutovitz D, Sudar D, Kallioniemi A, Kallioiemi OP, Waldman FM, Gray JW, Pinkel D: Computer Image Analysis of Comparative Genomic Hybridization. Cytometry 19: 1026, 1995.
24. Sauter G, Carroll P, Moch H, Kallioniemi A, Kerschmann R, Narayan P, Mihatsch MJ, Waldman FM: C-myc Copy number gains in bladder cancer detected by fluorescence in situ hybridization. Am J Pathol 146: 1131-1139, 1995.
25. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, De Vries S, Kerschmann R, Caroll P, Waldman F: Identification of Gains and Losses of DNA Sequences in Primary Bladder Cancer by Comparative Genomic Hybridization. Genes Chromosomes Cancer 12: 213-219, 1995.
26. Voorter C, Joos S, Bringuier PP, Vallinga M, Poddighe P, Schalken J, Du Manoir S, Ramaekers F, Lichter P, Hopman A: Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146: 1341-1354, 1995.
27. Spruck CH, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS: Two Molecular Pathways to Transitional Cell Carcinoma of the Bladder. Cancer Res 54: 784-788, 1994.
28. Sandberg AA: Chromosome changes in bladder cancer: clinical and other correlations. Cancer Genet Cytogenet 19: 163-75, 1986.
29. Sarkis AS, Dalbagi G, Cordon-Cardo C, Zhang ZF, Sheinfeld J, Fair WR, Herr HW, Reuter VE: Nuclear overexpression of P53 protein in transitional cell bladder carcinoma: a marker for disease progression. J Nat can inst Vol 85 1: 53-59, 1993.
30. Weinberg RA: Tumor supressor genes. Science 254: 1138-1146, 1992.